Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/40/3f/cd/403fcdc3-ccc9-b6e6-0102-412bca04eb74/mza_15681279475088147277.png/600x600bb.jpg
Breaking the Silence: Navigating Advanced Endometrial Cancer
Medscape
6 episodes
3 days ago
Endometrial cancer is one of the most common gynecological malignancies and the fifth most common cancer type in women. Diagnosis and treatment options have evolved during the past 10 years with the introduction of biomarkers that can inform treatment.
Show more...
Medicine
Health & Fitness
RSS
All content for Breaking the Silence: Navigating Advanced Endometrial Cancer is the property of Medscape and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Endometrial cancer is one of the most common gynecological malignancies and the fifth most common cancer type in women. Diagnosis and treatment options have evolved during the past 10 years with the introduction of biomarkers that can inform treatment.
Show more...
Medicine
Health & Fitness
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/40/3f/cd/403fcdc3-ccc9-b6e6-0102-412bca04eb74/mza_15681279475088147277.png/600x600bb.jpg
The Hottest Topic in Endometrial Cancer: Where Is the Therapeutic Landscape Moving to and What Are the Data to Support This?
Breaking the Silence: Navigating Advanced Endometrial Cancer
14 minutes 30 seconds
1 year ago
The Hottest Topic in Endometrial Cancer: Where Is the Therapeutic Landscape Moving to and What Are the Data to Support This?
Breaking the Silence: Navigating Advanced Endometrial Cancer
Endometrial cancer is one of the most common gynecological malignancies and the fifth most common cancer type in women. Diagnosis and treatment options have evolved during the past 10 years with the introduction of biomarkers that can inform treatment.